OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Circulating long-non coding RNAs as biomarkers of left ventricular diastolic function and remodelling in patients with well-controlled type 2 diabetes
David de Gonzalo‐Calvo, Franziska Kenneweg, Claudia Bang, et al.
Scientific Reports (2016) Vol. 6, Iss. 1
Open Access | Times Cited: 139

Showing 1-25 of 139 citing articles:

RNA delivery by extracellular vesicles in mammalian cells and its applications
Killian P. O’Brien, Koen Breyne, Stefano Ughetto, et al.
Nature Reviews Molecular Cell Biology (2020) Vol. 21, Iss. 10, pp. 585-606
Open Access | Times Cited: 1405

RNA-based diagnostic and therapeutic strategies for cardiovascular disease
Dongchao Lu, Thomas Thum
Nature Reviews Cardiology (2019) Vol. 16, Iss. 11, pp. 661-674
Closed Access | Times Cited: 271

Epigenetic Modifications in Cardiovascular Aging and Diseases
Weiqi Zhang, Moshi Song, Jing Qu, et al.
Circulation Research (2018) Vol. 123, Iss. 7, pp. 773-786
Open Access | Times Cited: 234

Diagnostic approaches for diabetic cardiomyopathy
Ana Lorenzo-Almorós, José Tuñón, Miguel Orejas, et al.
Cardiovascular Diabetology (2017) Vol. 16, Iss. 1
Open Access | Times Cited: 224

Diabetic Cardiomyopathy: Current and Future Therapies. Beyond Glycemic Control
Giulia Borghetti, Dirk von Lewinski, Deborah Eaton, et al.
Frontiers in Physiology (2018) Vol. 9
Open Access | Times Cited: 195

Non-coding RNAs regulating mitochondrial function in cardiovascular diseases
Xiang Ao, Wei Ding, Xiaoge Li, et al.
Journal of Molecular Medicine (2023) Vol. 101, Iss. 5, pp. 501-526
Closed Access | Times Cited: 50

LncRNAs in vascular biology and disease
Viorel Simion, Stefan Haemmig, Mark W. Feinberg
Vascular Pharmacology (2018) Vol. 114, pp. 145-156
Open Access | Times Cited: 155

Of mice and men: models and mechanisms of diabetic cardiomyopathy
Christian Riehle, Johann Bauersachs
Basic Research in Cardiology (2018) Vol. 114, Iss. 1
Open Access | Times Cited: 155

Long Non-coding RNAs: At the Heart of Cardiac Dysfunction?
Lisa Hobuß, Christian Bär, Thomas Thum
Frontiers in Physiology (2019) Vol. 10
Open Access | Times Cited: 115

Long non-coding RNAs in the atherosclerotic plaque
Serdal Arslan, Öcal Berkan, Torkia Lalem, et al.
Atherosclerosis (2017) Vol. 266, pp. 176-181
Closed Access | Times Cited: 104

The Function and Therapeutic Potential of Long Non-coding RNAs in Cardiovascular Development and Disease
Clarissa P. C. Gomes, Helen Spencer, K L Ford, et al.
Molecular Therapy — Nucleic Acids (2017) Vol. 8, pp. 494-507
Open Access | Times Cited: 102

Role of flow-sensitive microRNAs and long noncoding RNAs in vascular dysfunction and atherosclerosis
Sandeep Kumar, Darian Williams, Sanjoli Sur, et al.
Vascular Pharmacology (2018) Vol. 114, pp. 76-92
Open Access | Times Cited: 101

Endothelial dysfunction in diabetes and hypertension: Role of microRNAs and long non-coding RNAs
Hai-na Zhang, Xu Qiaoqiao, Abhimanyu Thakur, et al.
Life Sciences (2018) Vol. 213, pp. 258-268
Closed Access | Times Cited: 98

LncRNAs: key players and novel insights into diabetes mellitus
Xiaoyun He, Chunlin Ou, Yanhua Xiao, et al.
Oncotarget (2017) Vol. 8, Iss. 41, pp. 71325-71341
Open Access | Times Cited: 91

Noncoding RNAs in Cardiovascular Disease: Current Knowledge, Tools and Technologies for Investigation, and Future Directions: A Scientific Statement From the American Heart Association
Saumya Das, Ravi V. Shah, Stefanie Dimmeler, et al.
Circulation Genomic and Precision Medicine (2020) Vol. 13, Iss. 4
Open Access | Times Cited: 89

Circulating non-coding RNAs in biomarker-guided cardiovascular therapy: a novel tool for personalized medicine?
David de Gonzalo‐Calvo, Àngela Vea, Christian Bär, et al.
European Heart Journal (2018) Vol. 40, Iss. 20, pp. 1643-1650
Open Access | Times Cited: 88

Non‐coding RNA involvement in the pathogenesis of diabetic cardiomyopathy
Wei Zhang, Weiting Xu, Yu Feng, et al.
Journal of Cellular and Molecular Medicine (2019) Vol. 23, Iss. 9, pp. 5859-5867
Open Access | Times Cited: 81

The Impact of lncRNAs in Diabetes Mellitus: A Systematic Review and In Silico Analyses
Cristine Dieter, Natália Emerim Lemos, Nathalia Rodrigues de Faria Corrêa, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 56

Non-Coding RNAs: Prevention, Diagnosis, and Treatment in Myocardial Ischemia–Reperfusion Injury
Mihnea-Cosmin Marinescu, Andrada-Luciana Lazăr, Monica Mihaela Marta, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2728-2728
Open Access | Times Cited: 50

Diabetic cardiomyopathy: The role of microRNAs and long non-coding RNAs
Mirjana Mačvanin, Zoran Gluvić, Jelena Radovanović, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 26

MIAT LncRNA: A multifunctional key player in non-oncological pathological conditions
Yousra Zeinelabdeen, Tasneem Abaza, Montaser Bellah Yasser, et al.
Non-coding RNA Research (2024) Vol. 9, Iss. 2, pp. 447-462
Open Access | Times Cited: 9

Extracellular RNAs: A New Awareness of Old Perspectives
Noah Sadik, Lilian Cruz, Alessandra Gurtner, et al.
Methods in molecular biology (2018), pp. 1-15
Open Access | Times Cited: 79

Circulating miR-19b and miR-181b are potential biomarkers for diabetic cardiomyopathy
Camila Uribe Copier, Luis León, Mauricio Fernández, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 71

Page 1 - Next Page

Scroll to top